Osaic Holdings’s Fulcrum Therapeutics FULC Stock Holding History

Osaic Holdings’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$614	Sell	168 -103	-38%	-$627	﹤0.01%	7609
2026 Q1	$2.08K	Buy	271 +181	+201%	+$1.68K	﹤0.01%	7030
2025 Q4	$1.02K	Hold	90	–	–	﹤0.01%	7273
2025 Q3	$828	Hold	90	–	–	﹤0.01%	7421
2025 Q2	$619	Buy	+90	New	+$481	﹤0.01%	7303
2025 Q1	–	Sell	-95	Closed	-$447	–	7542
2024 Q4	$447	Hold	95	–	–	﹤0.01%	7045
2024 Q3	$339	Buy	+95	New	+$705	﹤0.01%	7082
2023 Q2	–	Sell	-9	Closed	-$26	–	7500
2023 Q1	$26	Buy	+9	New	+$81	﹤0.01%	7412
2021 Q4	–	Sell	-300	Closed	-$8K	–	7437
2021 Q3	$8K	Buy	+300	New	+$5.68K	﹤0.01%	6324
2020 Q4	–	Sell	-50	Closed	–	–	6456
2020 Q3	$0	Hold	50	–	–	﹤0.01%	6271
2020 Q2	$1K	Buy	+50	New	+$787	﹤0.01%	5935

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's FULC Position: Q2 2026 in Review

Osaic Holdings reduced its Fulcrum Therapeutics (FULC) stake by 38% in Q2 2026, selling an estimated $627 and leaving 168 shares worth $614. The position accounts for ﹤0.01% of the portfolio, ranked #7609.

Osaic Holdings first reported a position in FULC in Q2 2020 and has held it in 11 quarters since. The position peaked at $8K in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Osaic Holdings held 168 shares of Fulcrum Therapeutics worth $614 as of Q2 2026.
Osaic Holdings sold 103 Fulcrum Therapeutics shares in Q2 2026, an estimated $627.
Fulcrum Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7609 holding.
Osaic Holdings first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 11 quarters since.
Osaic Holdings's Fulcrum Therapeutics position peaked at $8K in Q3 2021.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.